|
🐜
|
Early safety indicators of COVID-19 convalescent plasma in 5,000 patients.
36 auth.
M. Joyner,
R. Wright,
D. Fairweather,
Jonathon W. Senefeld,
K. A. Bruno,
S. Klassen,
R. Carter,
A. Klompas,
C. Wiggins,
J. Shepherd,
R. Rea,
E. Whelan,
A. Clayburn,
Matthew R. Spiegel,
Patrick W. Johnson,
...
E. Lesser,
S. Baker,
K. Larson,
J. Ripoll,
K. Andersen,
D. Hodge,
K. Kunze,
M. Buras,
M. Vogt,
V. Herasevich,
J. Dennis,
R. Regimbal,
P. Bauer,
J. Blair,
C. V. van Buskirk,
J. Winters,
J. Stubbs,
N. Paneth,
N. Verdun,
P. Marks,
A. Casadevall
|
8 |
2020 |
8
🐜
|
|
🐜
|
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
40 auth.
M. Joyner,
R. Carter,
Jonathon W. Senefeld,
S. Klassen,
J. Mills,
Patrick W. Johnson,
E. Theel,
C. Wiggins,
K. A. Bruno,
A. Klompas,
E. Lesser,
K. Kunze,
M. Sexton,
J. D. Diaz Soto,
S. Baker,
...
J. Shepherd,
N. van Helmond,
N. Verdun,
P. Marks,
C. V. van Buskirk,
J. Winters,
J. Stubbs,
R. Rea,
D. Hodge,
V. Herasevich,
E. Whelan,
A. Clayburn,
K. Larson,
J. Ripoll,
K. Andersen,
M. Buras,
M. Vogt,
J. Dennis,
R. Regimbal,
P. Bauer,
J. Blair,
N. Paneth,
D. Fairweather,
R. Wright,
A. Casadevall
|
8 |
2021 |
8
🐜
|
|
🐜
|
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
38 auth.
M. Joyner,
J. Senefeld,
S. Klassen,
J. Mills,
P. Johnson,
E. Theel,
C. Wiggins,
K. A. Bruno,
A. Klompas,
E. Lesser,
K. Kunze,
M. Sexton,
J. D. Diaz Soto,
S. Baker,
J. Shepherd,
...
N. van Helmond,
C. V. van Buskirk,
J. Winters,
J. Stubbs,
R. Rea,
D. Hodge,
V. Herasevich,
E. Whelan,
A. Clayburn,
K. Larson,
J. Ripoll,
K. Andersen,
M. Buras,
M. Vogt,
J. Dennis,
R. Regimbal,
P. Bauer,
J. Blair,
N. Paneth,
D. Fairweather,
R. Wright,
R. Carter,
A. Casadevall
|
8 |
2020 |
8
🐜
|
|
🐜
|
Safety Update
40 auth.
M. Joyner,
K. A. Bruno,
S. Klassen,
K. Kunze,
Patrick W. Johnson,
E. Lesser,
C. Wiggins,
Jonathon W. Senefeld,
A. Klompas,
D. Hodge,
J. Shepherd,
R. Rea,
E. Whelan,
A. Clayburn,
Matthew R. Spiegel,
...
S. Baker,
K. Larson,
J. Ripoll,
K. Andersen,
M. Buras,
M. Vogt,
V. Herasevich,
J. Dennis,
R. Regimbal,
P. Bauer,
J. Blair,
C. V. van Buskirk,
J. Winters,
J. Stubbs,
N. van Helmond,
B. Butterfield,
M. Sexton,
J. D. Diaz Soto,
N. Paneth,
N. Verdun,
P. Marks,
A. Casadevall,
D. Fairweather,
R. Carter,
R. Wright
|
7 |
2020 |
7
🐜
|
|
🐜
|
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
18 auth.
Christina A. von Roemeling,
Yifan Wang,
Yaqing Qie,
Hengfeng Yuan,
Hai Zhao,
Xiujie Liu,
Zhaogang Yang,
Mingming Yang,
W. Deng,
K. A. Bruno,
...
Charles K. F. Chan,
Andrew S. Lee,
S. Rosenfeld,
Kyuson Yun,
Aaron J. Johnson,
D. Mitchell,
Wen Jiang,
Betty Y. S. Kim
|
7 |
2020 |
7
🐜
|
|
🐬
|
Update on coxsackievirus B3 myocarditis
D. Fairweather,
K. A. Bruno,
Yoon-kyu Sung
|
7 |
2012 |
7
🐬
|
|
🐜
|
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
23 auth.
S. Klassen,
Jonathon W. Senefeld,
Patrick W. Johnson,
R. Carter,
C. Wiggins,
S. Shoham,
B. Grossman,
J. P. Henderson,
J. Musser,
E. Salazar,
...
W. Hartman,
Nicole M. Bouvier,
Sean T. H. Liu,
L. Pirofski,
S. Baker,
N. van Helmond,
R. Wright,
D. Fairweather,
K. A. Bruno,
Zhen Wang,
N. Paneth,
A. Casadevall,
M. Joyner
|
6 |
2021 |
6
🐜
|
|
🐜
|
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
44 auth.
Rafael Blanco-Domínguez,
Raquel Sánchez-Díaz,
H. de la Fuente,
L. J. Jiménez-Borreguero,
Adela Matesanz-Marín,
Marta Relaño,
R. Jiménez-Alejandre,
B. Linillos-Pradillo,
K. Tsilingiri,
M. L. Martín-Mariscal,
Laura Alonso-Herranz,
G. Moreno,
R. Martín-Asenjo,
M. García-Guimarães,
K. A. Bruno,
...
E. Daudén,
I. González-Álvaro,
L. M. Villar-Guimerans,
Amaia Martínez-León,
A. M. Salvador-Garicano,
S. A. Michelhaugh,
Nasrien E Ibrahim,
J. Januzzi,
J. Kottwitz,
S. Iliceto,
M. Plebani,
C. Basso,
A. Baritussio,
M. Seguso,
R. Marcolongo,
M. Ricote,
D. Fairweather,
Héctor Bueno,
L. Fernández-Friera,
F. Alfonso,
A. Caforio,
D. Pascual-Figal,
Bettina Heidecker,
T. Lüscher,
Saumya Das,
V. Fuster,
B. Ibáñez,
F. Sánchez‐Madrid,
Pilar Martín
|
6 |
2021 |
6
🐜
|
|
🐜
|
Use of convalescent plasma in COVID‐19 patients with immunosuppression
20 auth.
Jonathon W. Senefeld,
S. Klassen,
S. Ford,
K. Senese,
C. Wiggins,
B. Bostrom,
M. Thompson,
S. Baker,
W. Nicholson,
Patrick W. Johnson,
...
R. Carter,
J. P. Henderson,
W. Hartman,
L. Pirofski,
R. Wright,
D. Fairweather,
K. A. Bruno,
N. Paneth,
A. Casadevall,
M. Joyner
|
6 |
2021 |
6
🐜
|
|
🐜
|
Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
23 auth.
S. Klassen,
Jonathon W. Senefeld,
Patrick W. Johnson,
R. Carter,
C. Wiggins,
S. Shoham,
B. Grossman,
J. P. Henderson,
J. Musser,
E. Salazar,
...
W. Hartman,
Nicole M. Bouvier,
Sean T. H. Liu,
L. Pirofski,
S. Baker,
N. van Helmond,
R. Wright,
D. Fairweather,
K. A. Bruno,
Zhen Wang,
N. Paneth,
A. Casadevall,
M. Joyner
|
6 |
2020 |
6
🐜
|
|
🐜
|
Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis
20 auth.
Michael Coronado,
K. A. Bruno,
L. Blauwet,
C. Tschöpe,
M. Cunningham,
S. Pankuweit,
S. Van Linthout,
E. Jeon,
D. McNamara,
J. Krejci,
...
J. Bienertová-Vašků,
E. J. Douglass,
E. Abston,
Adriana Bucek,
J. Frisancho,
Merci S. Greenaway,
Anneliese R. Hill,
H. Schultheiss,
L. Cooper,
D. Fairweather
|
6 |
2019 |
6
🐜
|
